Evoked potential

WiMi to Design A Hybrid BCI-Based Humanoid Control System

Retrieved on: 
Friday, June 23, 2023
Cloud, Holography, Suitability analysis, Augmented reality, Evoked potential, BCI, WIMI, Disability, EOG, NIRS, EMG, Support, SSVEP, Brain, Rehabilitation, Attention, Research, ERD, SVM, Random forest, Signal, Acquisition, Machine learning, EEG, Algorithm, Support vector machine, NIR, AR, Medical imaging, Instrumentation, Satellite navigation device, Video game, Electromyography, Electrooculography

BEIJING, June 23, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it had made significant progress in the field by developing a humanoid control system based on hybrid signals BCI.

Key Points: 
  • BEIJING, June 23, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it had made significant progress in the field by developing a humanoid control system based on hybrid signals BCI.
  • Finally, the decoding results are mapped to the humanoid robot control to realize the power of the humanoid robot.
  • Finally, the humanoid control system based on hybrid BCI technology can achieve more natural and precise control, which can be applied to many fields, such as the robot and disabled assistance.
  • The humanoid control system also has good applicability and operability and can be adapted to the needs and characteristics of different users.

New Digital Tool Empowers Young People to Advocate for Mental Health Policy Changes

Retrieved on: 
Thursday, May 19, 2022
Well, People, Evoked potential, Education, Ageing, Multimedia, View, Solution, Health, Health care reform, BIPOC, Advisory board, Young invincibles, Statistics, Culture, Awareness, Active Minds, Life, Congress, Organization, Human, Coronavirus Scientific Advisory Board (Turkey), Pell, Trust, School, Mental health, YI, Directory, Emotion, Medicine, Toy, Pharmaceutical industry, Public relations, Online shopping, Color

WASHINGTON, May 19, 2022 /PRNewswire/ -- Evokate, a new online tool to address the growing mental health challenges facing youth and young adults, launched today to give young adults access to resources and tools to learn how to advocate for mental health policy changes in their communities.

Key Points: 
  • Ahead of Mental Health Action Day, this new tool provides a new resource to empower young people to advance advocacy efforts
    WASHINGTON, May 19, 2022 /PRNewswire/ -- Evokate, a new online tool to address the growing mental health challenges facing youth and young adults, launched today to give young adults access to resources and tools to learn how to advocate for mental health policy changes in their communities.
  • Evokate, a new online tool to address the growing mental health challenges facing youth and young adults, launched today
    Evokate was created by the National Mental Health Advisory Board, a group of young adults from across the country, aged 16-24, committed to strengthening mental health awareness and advocacy efforts.
  • The survey also showed that a high percentage of youth and young adults did not feel adequately equipped to advocate for mental health issues in their communities.
  • "Evokate gives youth and young adults the framework to utilize mental health resources to work toward increased mental health care access and equity in their communities."

LumiThera, Inc. Announces Creation of a Light-based Theranostic Approach to Treat Ocular Disease with Acquisition of Diopsys, Inc.

Retrieved on: 
Thursday, November 11, 2021
Population, Vision, ITT, R, BL, Eye, European Union, CEO, Disease, Ageing, Technology, PBM, CE marking, Food, Machine learning, Union, ERG, FDA, AMD, Severe cognitive impairment, Degenerative disease, Acquisition, CS, Evoked potential, Electroretinography, Diagnosis, Visual acuity, Physician, Diospi Suyana, Prevalence, Patient, Month, Letter, VEP, EU, Retina, Medical device, Pharmaceutical industry, Medical imaging

The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage.

Key Points: 
  • The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage.
  • Previously, LumiThera reported the U.S. LIGHTSITE III dry Age-related Macular Degeneration (AMD) trial fully enrolled 100 subjects in 1Q of 2021.
  • The LIGHTSITE III trial is continuing to move forward with the 13-month efficacy timepoint for all patients anticipated in 1Q of 2022.
  • The company is commercializing the office based Valeda Light Delivery System to be used by eyecare providers as medical treatments.

LumiThera, Inc. Announces Creation of a Light-based Theranostic Approach to Treat Ocular Disease with Acquisition of Diopsys, Inc.

Retrieved on: 
Thursday, November 11, 2021
Population, Vision, ITT, R, BL, Eye, European Union, CEO, Disease, Ageing, Technology, PBM, CE marking, Food, Machine learning, Union, ERG, FDA, AMD, Severe cognitive impairment, Degenerative disease, Acquisition, CS, Evoked potential, Electroretinography, Diagnosis, Visual acuity, Physician, Diospi Suyana, Prevalence, Patient, Month, Letter, VEP, EU, Retina, Medical device, Pharmaceutical industry, Medical imaging

The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage.

Key Points: 
  • The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage.
  • Previously, LumiThera reported the U.S. LIGHTSITE III dry Age-related Macular Degeneration (AMD) trial fully enrolled 100 subjects in 1Q of 2021.
  • The LIGHTSITE III trial is continuing to move forward with the 13-month efficacy timepoint for all patients anticipated in 1Q of 2022.
  • The company is commercializing the office based Valeda Light Delivery System to be used by eyecare providers as medical treatments.

Headsafe Announces FDA Clearance and U.S. Launch of its NUROCHEK™ Portable Brain Assessment System

Retrieved on: 
Wednesday, May 6, 2020
Branches of biology, Neuroscience, Medicine, Neurotechnology, Electrodiagnosis, Medical tests, Brain–computer interfacing, Evoked potential, Veps, Electroencephalography

The NUROCHEK system is intended for use in patients aged 14 years and older as indicator of brain function and is the worlds first portable Visual Evoked Potential (VEP) testing system for use at the point-of-care.

Key Points: 
  • The NUROCHEK system is intended for use in patients aged 14 years and older as indicator of brain function and is the worlds first portable Visual Evoked Potential (VEP) testing system for use at the point-of-care.
  • The NUROCHEK system is a portable brain assessment device that provides an objective measure of brain function that utilizes VEPs.
  • In under 3 minutes, the NUROCHEK system captures and transmits VEP stimulated Electroencephalography (EEG) data to a smartphone application for processing and secure cloud storage.
  • The companys NUROCHEK portable brain assessment system is cleared for use in the United States and will become available in other regions subject to regulatory approvals.

ATEC Announces Commercial Launch of the SafeOp Neural InformatiX System™

Retrieved on: 
Tuesday, November 26, 2019
Branches of biology, Electroencephalography, Neuroscience, Clinical medicine, Electrophysiology, Neurophysiology, Electrodiagnosis, Evoked potential, Somatosensory evoked potential, Electromyography, SSEP, Somatosensory system

CARLSBAD, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (ATEC or the Company) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of the SafeOp Neural InformatiX System (SafeOp), which has been designed to seamlessly integrate critical neural information into ATEC procedural solutions.

Key Points: 
  • CARLSBAD, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (ATEC or the Company) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of the SafeOp Neural InformatiX System (SafeOp), which has been designed to seamlessly integrate critical neural information into ATEC procedural solutions.
  • The commercial launch of the SafeOp System follows successful alpha evaluations that began earlier this year, and is the last of 12 planned commercial launches for 2019, delivering on ATECs commitment to accelerate growth through clinical distinction.
  • SafeOps unprecedented combination of nerve identification and nerve health information will be the cornerstone of ATEC clinical distinction.
  • The SafeOp Neural InformatiX System has been engineered with electromyography (EMG) and somatosensory evoked potentials (SSEP) to provide surgeons with actionable information regarding both the location and the health of nerves at risk during surgery.

Visiongain Publishes Global Nerve Monitoring System Market 2019-2029 Report

Retrieved on: 
Wednesday, May 15, 2019
Branches of biology, Organ systems, Neuroscience, Electrodiagnosis, Electrophysiology, Neurophysiology, Neurotechnology, Electroencephalography, Nerve injury, Electrocorticography, Evoked potential, Nerve

LONDON, May 15, 2019 /PRNewswire/ -- Global Nerve Monitoring System Market by Product (Nerve Monitors, Nerve Stimulation Electrodes and Probes and Accessories), Technology {Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG) and Evoked Potential (EP)} Application (Neurosurgery, Spine Surgery, ENT Surgery, Cardiovascular Applications and Other Applications), by End User (Hospitals & Surgical Centers and Ambulatory Surgical Centers), Global Opportunity Analysis and Industry Forecast

Key Points: 
  • LONDON, May 15, 2019 /PRNewswire/ -- Global Nerve Monitoring System Market by Product (Nerve Monitors, Nerve Stimulation Electrodes and Probes and Accessories), Technology {Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG) and Evoked Potential (EP)} Application (Neurosurgery, Spine Surgery, ENT Surgery, Cardiovascular Applications and Other Applications), by End User (Hospitals & Surgical Centers and Ambulatory Surgical Centers), Global Opportunity Analysis and Industry Forecast
    Nerve monitoring system are used to identify and monitor motor nerve function to reduce the risk of nerve damage.
  • The nerve monitoring system helps neurophysiologist to keep the records of the functioning nerve that helps to avoid fatal situations like irreversible nerve damage during any surgical procedures.
  • Recent advancements in nerve monitoring technology will intensify the applications and will augment business growth in foresee future.
  • Increasing availability of medical reimbursement specifically for nerve monitoring procedures, and growing demand for surgical intervention especially in trauma cases are the factors stimulating the market growth.

Visiongain Publishes Global Nerve Monitoring System Market 2019-2029 Report

Retrieved on: 
Wednesday, May 15, 2019
Branches of biology, Organ systems, Neuroscience, Electrodiagnosis, Electrophysiology, Neurophysiology, Neurotechnology, Electroencephalography, Nerve injury, Electrocorticography, Evoked potential, Nerve

LONDON, May 15, 2019 /PRNewswire/ -- Global Nerve Monitoring System Market by Product (Nerve Monitors, Nerve Stimulation Electrodes and Probes and Accessories), Technology {Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG) and Evoked Potential (EP)} Application (Neurosurgery, Spine Surgery, ENT Surgery, Cardiovascular Applications and Other Applications), by End User (Hospitals & Surgical Centers and Ambulatory Surgical Centers), Global Opportunity Analysis and Industry Forecast

Key Points: 
  • LONDON, May 15, 2019 /PRNewswire/ -- Global Nerve Monitoring System Market by Product (Nerve Monitors, Nerve Stimulation Electrodes and Probes and Accessories), Technology {Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG) and Evoked Potential (EP)} Application (Neurosurgery, Spine Surgery, ENT Surgery, Cardiovascular Applications and Other Applications), by End User (Hospitals & Surgical Centers and Ambulatory Surgical Centers), Global Opportunity Analysis and Industry Forecast
    Nerve monitoring system are used to identify and monitor motor nerve function to reduce the risk of nerve damage.
  • The nerve monitoring system helps neurophysiologist to keep the records of the functioning nerve that helps to avoid fatal situations like irreversible nerve damage during any surgical procedures.
  • Recent advancements in nerve monitoring technology will intensify the applications and will augment business growth in foresee future.
  • Increasing availability of medical reimbursement specifically for nerve monitoring procedures, and growing demand for surgical intervention especially in trauma cases are the factors stimulating the market growth.

Nihon Kohden Launches Neuropack® S3 Electrodiagnostic System Offering Unparalleled Clean Waveforms

Retrieved on: 
Wednesday, May 1, 2019
Technology, Data management, Software, Practice Management, Health, Hospitals, Manufacturing, Other Manufacturing, Branches of biology, Medicine, Clinical medicine, Electrophysiology, Neurophysiology, Electrodiagnosis, Electrodiagnostic medicine, Neurology, Rehabilitation medicine, Electromyography, Evoked potential, edX

Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the launch of its Neuropack S3 electrodiagnostic (EDX) system, an advanced multimodality platform for neurodiagnostic procedures.

Key Points: 
  • Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the launch of its Neuropack S3 electrodiagnostic (EDX) system, an advanced multimodality platform for neurodiagnostic procedures.
  • Featuring the companys latest-generation amplifiers and signal processing technology, the Neuropack S3 is designed to offer high-quality EDX studies while minimizing footprint and improving portability.
  • The Neuropack S3 system was developed to be flexible enough for use in both hospitals and private practices to conduct electromyography, nerve conduction studies, evoked potentials, and other diagnostic procedures.
  • At Nihon Kohden, we pride ourselves in providing unsurpassed quality and reliability of the signal quality from our amplifiers, said John Korney, vice president, marketing, Nihon Kohden America.

Nerve Monitoring Devices Market to Gain Based on Continuous Advancement in Medical Technology: Radiant Insights, Inc.

Retrieved on: 
Thursday, March 14, 2019
Branches of biology, Neuroscience, Medicine, Neurophysiology, Electrodiagnosis, Electrophysiology, Neurotechnology, Electroencephalography, Nerve conduction study, Evoked potential, Electromyography, Nerve injury

Nerve monitoring devices allow specialists to recognize and monitor brain disorders such as spinal cord & peripheral nerve dysfunction, brain alterations and irreversible nerve damage.

Key Points: 
  • Nerve monitoring devices allow specialists to recognize and monitor brain disorders such as spinal cord & peripheral nerve dysfunction, brain alterations and irreversible nerve damage.
  • Market of nerve monitoring devices based on modality could span Electromyography/nerve conduction studies/evoked potential (EMG/NCS/EP), Electroencephalography (EEG) and Magnetoencephalography (MEG).
  • Nerve monitoring devices market is categorized based on geography into North America, Latin America, Japan, Middle East, and Africa, Western Europe, Asia Pacific, and Eastern Europe.
  • Key players operating in the nerve monitoring devices market include NuVasive, Inc., Medtronic, Inomed, Magnetism, NIHON KOHDEN CORPORATION, NeuroSign, EMS Biomedical, Natus Medical Incorporated, Deymed Diagnostic, and Dr. Langer Medical GmbH.